Thermo Fisher Scientific Inc. (TMO)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Marc N. Casper | Chairman, President & CEO | 5.08M | 47.09M | 1968 |
| Mr. Stephen Williamson | Senior VP & CFO | 2.02M | 10.57M | 1967 |
| Mr. Michel Lagarde | Executive VP & COO | 2.22M | -- | 1975 |
| Mr. Gianluca Pettiti | Executive Vice President | 1.66M | 911.34k | 1979 |
| Mr. Joseph R. Holmes | VP & Chief Accounting Officer | -- | -- | 1980 |
| Mr. Ryan J. Snyder | Senior VP & Chief Information Officer | -- | -- | -- |
| Dr. Karen E. Nelson Ph.D. | Chief Scientific Officer | -- | -- | -- |
| Mr. Rafael Tejada | Vice President of Investor Relations | -- | -- | -- |
| Mr. Frederick M. Lowery | Senior VP & President of Customer Channels | -- | -- | 1972 |
| Dr. Alan B. Sachs M.D., Ph.D. | Chief Medical Officer | -- | -- | -- |
Thermo Fisher Scientific Inc.
- Sector:
- Healthcare
- Industry: Diagnostics & Research
- Full Time Employees:
- 122,000
Description
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Corporate Governance
Recent Events
- Apr 15, 2024Dividend Date
- Apr 09, 2024DEF 14A: Proxy StatementsSee Full Filing
- Mar 14, 2024SC 13D/A: Tender Offer/Acquisition ReportsSee Full Filing
- Mar 14, 2024Ex-Dividend Date
- Mar 06, 2024SC TO-T/A: Tender Offer/Acquisition ReportsSee Full Filing